In this proposal, the Commission undertakes to propose recourse to the regulatory procedure referred to in Articles 5 and 7 of Decision 1999/468/EC for the adoption of final public-health protection measures in respect of marketing authorisations which may be necessitated as a result of evaluation of pharmacovigilance data (measures provided for in the new proposal to amend or replace the fourth subparagraph of Article 107(2) of Directive 2001/83/EC).
